cidrap.umn8h
Studies show more promising results for RSV drug nirsevimab
The first study, published yesterday in Clinical Infectious Diseases, includes results of a phase 3 clinical trial (MELODY), ...
psychiatryadvisor.com15h
Studies Examine Cost-Effectiveness of Maternal RSV Vaccination, Nirsevimab in Infants
Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness.
Medscape19h
Nirsevimab Reduces Risk for Severe RSV Among American Indian and Alaskan Native Children
Use of nirsevimab was associated with an approximately 80% reduction in illness due to respiratory syncytial virus (RSV) ...